Hutchmed (China) Limited
HCM | HKEX
Overview
Corporate Details
- ISIN(s):
 - KYG4672N1198 (+1 more)
 - LEI:
 - 2138006X34YDQ6OBYE79
 - Country:
 - Hong Kong
 - Address:
 - LEVEL 18, THE METROPOLIS TOWER, KOWLOON
 - Website:
 - https://www.hutch-med.com/
 - Sector:
 - Manufacturing
 - Industry:
 - Manufacture of pharmaceuticals, medicinal chemical and botanical products
 
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-03 08:30 | 
                         Regulatory News Service 
                        Updates from R&D Event 
                     | 
                    English | 23.6 KB | ||
| 2025-10-23 08:00 | 
                         Regulatory News Service 
                        HUTCHMED Presents Data at AACR NCI EORTC 
                     | 
                    English | 20.4 KB | ||
| 2025-10-21 10:30 | 
                         Remuneration Information 
                        Vesting of awards under Long Term Incentive Plan  
                     | 
                    English | 41.6 KB | ||
| 2025-10-14 10:30 | 
                         Board/Management Information 
                        Appointment of Independent Non-executive Director 
                     | 
                    English | 20.0 KB | ||
| 2025-10-13 08:05 | 
                         Earnings Release 
                        Data to be Presented at the 2025 ESMO Congress 
                     | 
                    English | 23.1 KB | ||
| 2025-10-02 08:00 | 
                         Regulatory News Service 
                        HUTCHMED Highlights Data to be Presented at ESMO 
                     | 
                    English | 32.5 KB | ||
| 2025-09-30 10:30 | 
                         Declaration of Voting Results & Voting Rights Announcements 
                        Total Voting Rights 
                     | 
                    English | 13.3 KB | ||
| 2025-08-26 08:00 | 
                         Board/Management Information 
                        Directorate Change 
                     | 
                    English | 17.9 KB | ||
| 2025-08-20 08:00 | 
                         Regulatory News Service 
                        HUTCHMED Completes Enrollment of Phase III Trial 
                     | 
                    English | 29.1 KB | ||
| 2025-08-07 13:00 | 
                         Earnings Release 
                        2025 Interim Results 
                     | 
                    English | 141.5 KB | ||
| 2025-07-03 10:30 | 
                         Report Publication Announcement 
                        HUTCHMED to Announce 2025 Half-Year Results 
                     | 
                    English | 12.1 KB | ||
| 2025-06-30 10:30 | 
                         Declaration of Voting Results & Voting Rights Announcements 
                        Total Voting Rights 
                     | 
                    English | 12.4 KB | ||
| 2025-06-30 10:30 | 
                         Remuneration Information 
                        Blocklisting Six Monthly Return 
                     | 
                    English | 25.1 KB | ||
| 2025-06-30 10:30 | 
                         Regulatory News Service 
                        China Approval based on Phase III SACHI Trial  
                     | 
                    English | 29.8 KB | 
Automate Your Workflow. Get a real-time feed of all Hutchmed (China) Limited filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Hutchmed (China) Limited
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Hutchmed (China) Limited via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value | 
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||